ChargePoint Just Gained 61% in a Month: Is It Too Late to Buy CHPT Stock Now?

ChargePoint shares surged 61% over the past month to $9.48, including a 6% gain Thursday, despite no identified company-specific catalyst and while peers Blink Charging, EVgo and the DRIV EV ETF each fell 6%. Q2 FY2027 results provide supportive context—revenue rose 17.7% year over year to $116.08 million, non-GAAP gross margin reached 38%, and adjusted EBITDA loss narrowed to $5 million from $22 million—but the company still reported a $36.1 million shareholders' deficit and $95.33 million of cash. The unexplained, stock-specific rally raises reversal risk if buying momentum fades or no new disclosure emerges.

Analysis

CHPT’s isolated appreciation is more likely a positioning/liquidity event than a durable charging-industry re-rating until filings identify a fundamental trigger. In a capital-intensive category, equity value is governed less by a quarter of margin progress than by the path to self-funded operations; the remaining cash balance and shareholder deficit leave dilution sensitivity high if working-capital needs, warranty costs, or DC-fast-charger deployment spending reaccelerate. A higher share price may itself create an opportunistic financing window, which is a medium-term ceiling rather than an immediate catalyst.

The key distinction versus EVGO is business model exposure: CHPT’s hardware/software mix can show faster gross-margin recovery, but its distributed commercial-customer base makes revenue more sensitive to enterprise capex delays and channel inventory. ETN gains strategically if charging infrastructure deployment broadens, but the partnership alone is unlikely to move Eaton’s earnings base; any read-through should be expressed in CHPT, not ETN. BLNK remains the weaker comparator given its more persistent funding and execution burden, but peer underperformance means a sector-long thesis has not been validated.

Over the next days, failure to hold the post-rally range without a disclosed catalyst would support a momentum unwind, especially if volume fades. Over 1-3 months, the next earnings release must convert improved adjusted EBITDA into operating cash-flow evidence and preserve gross margin while revenue scales; otherwise the multiple will compress back toward distressed small-cap charging peers. The contrarian upside is that a strategic investment, asset sale, or material commercial win may have leaked into positioning, but that is not investable absent verification.

Key Decisions for Investors

• Do not chase CHPT outright at current levels; place on an event-driven watchlist for an 8-K, financing disclosure, insider activity, or customer/partner announcement. Initiate only after the catalyst is identified or after a 20-30% retracement that holds on declining volume.
• For a tactical mean-reversion book, consider a small short CHPT / long EVGO pair only if CHPT breaks the prior week’s support on elevated volume; target a 15-25% narrowing of the relative-performance gap over 1-3 months. Stop if CHPT discloses a strategic transaction, material contract, or raises full-year profitability expectations.
• Require next-quarter operating cash flow, not adjusted EBITDA alone, as the fundamental confirmation threshold for a CHPT long. A renewed cash burn expansion, lower gross-margin guidance, or an equity/convertible raise should falsify the re-rating thesis.
• Keep ETN neutral: the charging relationship is strategically positive but too small relative to Eaton’s diversified electrical backlog to justify a standalone trade. Revisit only if management quantifies charging-related order growth or data-center/electrification demand creates a broader multiple catalyst.